Around the globe, the growing class of weight loss drugs called GLP-1 agonists has been a game-changer. This includes the blockbuster drug semaglutide, better known by its brand names Ozempic and the more potent Wegovy. These have helped people lose weight, feel more confident and be healthier.
But a surge in demand and a high price tag have led to a rise in counterfeit versions of the drugs – causing hospitalisations around the world.
